Silco Pharmaceuticals Limited
  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us
Select Page

By Generic Name

Showing 61–72 of 78 results

  • Naproxen Sodium , Esomeprazole Magnesium Trihydrate

    Naproxen Sodium , Esomeprazole Magnesium Trihydrate

  • Omeprazole

    Omeprazole

  • Omeprazole

    Omeprazole

  • Pantoprazole Sodium Sesquihydrate

    Pantoprazole Sodium Sesquihydrate

  • Pantoprazole Sodium Sesquihydrate

    Pantoprazole Sodium Sesquihydrate

  • Paracetamol

    Paracetamol

  • Paracetamol

    Paracetamol

  • Ranitidine Hydrochloride

    Ranitidine Hydrochloride

  • Salbutamol Sulphate

    Salbutamol Sulphate

  • Thiamine HCl  (B1) , Riboflavin 5-Phosphate Sodium (B2 ) , Pyridoxine HCl (B6) , Nicotinamide , ZnSO4.H20

    Thiamine HCl (B1) , Riboflavin 5-Phosphate Sodium (B2 ) , Pyridoxine HCl (B6) , Nicotinamide , ZnSO4.H20

  • Thiamine HCl (B1) , Pyridoxine HCl (B6)  , Cyanocobalamin (B12)

    Thiamine HCl (B1) , Pyridoxine HCl (B6) , Cyanocobalamin (B12)

  • Thiamine HCl (B1) , Pyridoxine HCl (B6) , Riboflavin (B2) , Nicotinamide

    Thiamine HCl (B1) , Pyridoxine HCl (B6) , Riboflavin (B2) , Nicotinamide

  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • →

Registered & Head Office

Nurani-41, Ban-Kalapara, Subid Bazar, Sylhet-3100, Bangladesh.

Phone: +8802996638241

E-mail:  info@silcopharma.com

 

 

 

 

 

 

 

 

 

 

 

 

 

ABOUT US

  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us

PRODUCTS

  • By Trade Name
  • By Generic Name
  • By Therapeutic Class

FACILITIES

  • Quality Policy
  • Manufacturing Facility
  • Quality Assurance
  • HVAC system
  • Cephalosporin Unit
  • Wastewater Treatment
  • Facebook
  • Twitter
  • Google
  • Youtube
  • RSS
© Silcopharma 2024 || Designed and Develop by Momi Technology LLC